NY Pub Health L § 3306 (2021)
2021 New York Laws PBH - Public Health Article 33 - Controlled Substances Title 1 - General Provisions 3306 - Schedules of Controlled Substances.

§  3306.  Schedules  of  controlled  substances.    There  are  hereby established five schedules of controlled  substances,  to  be  known  as schedules  I,  II,  III,  IV  and  V  respectively. Such schedules shall consist of  the  following  substances  by  whatever  name  or  chemical designation known:   Schedule  I.  (a)  Schedule  I  shall  consist  of the drugs and other substances, by whatever official name, common or  usual  name,  chemical name, or brand name designated, listed in this section.  (b)  Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and  ethers,  whenever  the existence  of  such isomers, esters, ethers and salts is possible within the specific chemical  designation  (for  purposes  of  3-methylfentanyl only, the term isomer includes the optical and geometric isomers):  (1) Acetyl-alpha-methylfentanyl          (N-{1-(-methyl-2-phenethyl) -4-piperidinyl} -N-phenylacetamide.  (2) Acetylmethadol.  (3) Allylprodine.  (4) Alphacetylmethadol (except levo- alphacetylmethadol also known  as levo-alpha-acetylmethadol, levomethadylacetate or LAAM).  (5) Alphameprodine.  (6) Alphamethadol.  (7) Alpha-methylfentanyl            (N-{1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl}      propionanilide;       1-(1-methyl-2-phenylethyl) -4-(N-propanilido) piperidine).  (8) Alpha-methylthiofentanyl               (N-{1-methyl-2)2-thienyl) ethyl-4-piperidinyl} -N-phenylpropanamide).  (9) Beta-hydroxyfentanyl (N-{1-2 (2-hydroxy-2-phenethyl)- 4-piperidinyl} -N-phenylpropanamide).  (10) Beta-hydroxy-3-methylfentanyl  other       name:       N-{1- (2-hydroxy-2-phenethyl) -3-methyl -4-piperidinyl} -N-phenylpropanamide.  (11) Benzethidine.  (12) Betacetylmethadol.  (13) Betameprodine.  (14) Betamethadol.  (15) Betaprodine.  (16) Clonitazene.  (17) Dextromoramide.  (18) Diampromide.  (19) Diethylthiambutene.  (20) Difenoxin.  (21) Dimenoxadol.  (22) Dimepheptanol.  (23) Dimethylthiambutene.  (24) Dioxaphetyl butyrate.  (25) Dipipanone.  (26) Ethylmethylthiambutene.  (27) Etonitazene.  (28) Etoxeridine.  (29) Furethidine.  (30) Hydroxypethidine.  (31) Ketobemidone.  (32) Levomoramide.  (33) Levophenacylmorphan.  (34) 3-MethylfentanylN-{3-methy1-1- (2- phenylethyl -4-piperidyl} -N-phenylpropanamide).  (35) 3-Methylthiofentanyl         N-{3-methyl-1- (2-thienyl)ethyl -4-piperidinyl} -N-phenylpropanamide).  (36) Morpheridine.  (37) MPPP (1-methyl -4-phenyl -4-propionoxypiperidine).  (38) Noracymethadol.  (39) Norlevorphanol.  (40) Normethadone.  (41) Norpipanone.  (42) Para-fluorofentanyl N- (4-fluorophenyl) -N-{1- (2-phenethyl) -4-piperidinyl} -propanamide.  (43) PEPAP (1- (-2-phenethyl) -4-phenyl -4-acetoxypiperidine.  (44) Phenadoxone.  (45) Phenampromide.  (46) Phenomorphan.  (47) Phenoperidine.  (48) Piritramide.  (49) Proheptazine.  (50) Properidine.  (51) Propiram.  (52) Racemoramide.  (53)  Thiofentanyl  (N-phenyl-N-{1- (2-thienyl) ethyl -4- piperidinyl} -propanamide.  (54) Tilidine.  (55) Trimeperidine.  (56) 3,4-dichloro-N-{(1-dimethylamino)cyclohexylmethyl}benzamide. Some trade or other names: AH-7921.  (57) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide.  Some  trade  or other names: Acetyl Fentanyl.  (58)  N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide.  Other   name: Butyryl Fentanyl.  (59) N-{1-{2-hydroxy-2-(thiophen-2-yl)ethyl}piperidin-4-yl}-N-phenylp- ropionamide. Other name: Beta-Hydroxythiofentanyl.  (60)  N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide. Other name: Furanyl Fentanyl.  (61) 3,4-Dichloro-N-{2-(dimethylamino)  cyclohexyl}-N-methylbenzamide. Other name: U-47700.  (62)  N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide.  Other  names: Acryl Fentanyl or Acryloylfentanyl.  (63)    N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide. Other    names:   4-fluoroisobutyryl   fentanyl,   para-fluoroisobutyryl fentanyl.  (64)     N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide. Other names: ortho-fluorofentanyl or 2-fluorofentanyl.  (65)   N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carbox- amide. Other name: tetrahydrofuranyl fentanyl.  (66) 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide.  Other name: methoxyacetyl fentanyl.  (67) N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide. Other name: cyclopropyl fentanyl.  (68) N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide. Other name: para-fluorobutyrylfentanyl.  (69) N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetam- ide. Other name: Ocfentanil.  (70) 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine. Other name: MT-45.  (c)  Opium  derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its  salts, isomers,  and  salts  of  isomers  whenever the existence of such salts, isomers, and salts of isomers is possible within the  specific  chemical designation:  (1) Acetorphine.  (2) Acetyldihydrocodeine.  (3) Benzylmorphine.  (4) Codeine methylbromide.  (5) Codeine-N-oxide.  (6) Cyprenorphine.  (7) Desomorphine.  (8) Dihydromorphine.  (9) Drotebanol.  (10) Etorphine (except hydrochloride salt).  (11) Heroin.  (12) Hydromorphinol.  (13) Methyldesorphine.  (14) Methyldihydromorphine.  (15) Morphine methylbromide.  (16) Morphine methylsulfonate.  (17) Morphine-N-oxide.  (18) Myrophine.  (19) Nicocodeine.  (20) Nicomorphine.  (21) Normorphine.  (22) Pholcodine.  (23) Thebacon.  (d)  Hallucinogenic substances. Unless specifically excepted or unless listed  in  another  schedule,  any  material,  compound,  mixture,   or preparation, which contains any quantity of the following hallucinogenic substances,  or  which  contains any of its salts, isomers, and salts of isomers whenever the existence of such  salts,  isomers,  and  salts  of isomers  is  possible  within  the  specific  chemical  designation (for purposes of this paragraph only, the term "isomer" includes the optical, position and geometric isomers):  (EXPLANATION--Within  the  following  chemical  designations,  character   symbol  substitutions  were  made from the original text:  "@" = Greek   alpha, "&" = Greek beta, "'" = prime mark and "/\" = triangle.)  (1) 4-bromo-2, 5-dimethoxy-amphetamine  Some  trade  or  other  names: 4-bromo-2, 5-dimethoxy-@-methylphenethylamine; 4-bromo-2, 5-DMA.  (2) 2, 5-dimethoxyamphetamine    Some    trade    or    other   names: 2, 5-dimethoxy-@-methylphenethylamine; 2, 5-DMA.  (3) 4-methoxyamphetamine    Some     trade     or     other     names: 4-methoxy-@-methylphenethylamine; paramethoxyamphetamine, PMA.  (4) 5-methoxy-3, 4-methylenedioxy - amphetamine.  (5) 4-methyl-2,  5-dimethoxy-amphetamine  Some  trade and other names: 4-methyl-2, 5-dimethoxy-@-methylphenethylamine; "DOM"; and "STP".  (6) 3, 4-methylenedioxy amphetamine.  (7) 3, 4, 5-trimethoxy amphetamine.  (8) Bufotenine Some trade and other names:  3-(&-dimethylaminoethyl)-5 hydroxindole;                       3-(2-dimethylaminoethyl)- 5-indolol; N, N-dimethylserotonin; -5-hydroxy-N, N-dimethyltryptamine; mappine.  (9) Diethyltryptamine      Some     trade     and     other     names: N, N-diethyltryptamine; DET.  (10) Dimethyltryptamine Some trade or other names: DMT.  (11) Ibogane Some trade and other names: 7-ethyl-6, 6&, 7, 8,  9,  10, 12,  13-octahydro-2-methoxy-6,  9-methano-5h-pyrido  {1',2':1,2} azepino {5,4-b} indole: tabernanthe iboga.  (12) Lysergic acid diethylamide.  (13) Mescaline.  (14)  Parahexyl.  Some  trade  or  other   names:   3-Hexyl-1-hydroxy- 7,8,9,10-tetra hydro-6,6,9-trimethyl-6H-dibenfo{b,d} pyran.  (15)  Peyote.  Meaning  all  parts  of  the plant presently classified botanically as Lophophora williamsii Lemaire, whether  growing  or  not, the  seeds  thereof,  any extract from any part of such plant, and every compound, manufacture, salts, derivative,  mixture,  or  preparation  of such plant, its seeds or extracts.  (16) N-ethyl-3-piperidyl benzilate.  (17) N-methyl-3-piperidyl benzilate.  (18) Psilocybin.  (19) Psilocyn.  (20)   Tetrahydrocannabinols.   Synthetic   tetrahydrocannabinols  not derived from the cannabis plant that are equivalents of  the  substances contained  in the plant, or in the resinous extractives of cannabis, sp. and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following:   delta 1 cis or trans tetrahydrocannabinol, and their optical isomers   delta 6 cis or trans tetrahydrocannabinol, and their optical isomers   delta 3, 4 cis or trans tetrahydrocannabinol, and its optical  isomers (since   nomenclature   of   these  substances  is  not  internationally standardized, compounds of these  structures,  regardless  of  numerical designation  of  atomic  positions  covered).  Any Federal Food and Drug Administration approved product  containing  tetrahydrocannabinol  shall not be considered a synthetic tetrahydrocannabinol.  (21)  Ethylamine  analog  of phencyclidine. Some trade or other names: N-ethyl-1-phenylcyclohexylamine,  (1-phenylcyclohexyl)     ethylamine, N-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE.  (22) Pyrrolidine  analog  of  phencyclidine. Some trade or other names 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy, PHP.  (23) Thiophene analog of phencyclidine. Some  trade  or  other  names: 1-{1-(2-thienyl)-cyclohexyl}-piperidine,        2-thienylanalog       of phencyclidine, TPCP, TCP.  (24) 3,4-methylenedioxymethamphetamine (MDMA).  (25) 3,4-methylendioxy-N-ethylamphetamine also      known      as N-ethyl-alpha-methyl-3,4  (methylenedioxy)  phenethylamine, N-ethyl MDA, MDE, MDEA.  (26)   N-hydroxy-3,4-methylenedioxyamphetaminealso    known    as N-hydroxy-alpha-methyl-3,4  (methylenedioxy)    phenethylamine,    and N-hydroxy MDA.  (27) 1-{1- (2-thienyl)  cyclohexyl}  pyrrolidine.  Some  other  names: TCPY.  (28)  Alpha-ethyltryptamine.  Some  trade or other names: etryptamine; Monase;  Alpha-ethyl-1H-indole-3-ethanamine;  3- (2-aminobutyl)  indole; Alpha-ET or AET.  (29)  2,5-dimethoxy-4-ethylamphetamine.  Some  trade  or  other names: DOET.  (30) 4-Bromo-2,5-dimethoxyphenethylamine. Some trade or  other  names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane;    alpha-desmethyl   DOB; 2C-B, Nexus.  (31)   2,5-dimethoxy-4-(n)-propylthiophenethylamine   (2C-T-7),    its optical isomers, salts and salts of isomers.  (33) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, also known as 25I-NBOMe; 2C-I-NBOMe; 25I; or Cimbi-5.  (34) 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, also known as 25 CNBOMe; 2C-C-NBOMe; 25C; or Cimbi-82.  (35) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, also known as, 25 BNBOMe; 2C-B-NBOMe; Cimbi-36.  (36) 5-methoxy-N,N-dimethyltryptamine.  (37) Alpha-methyltryptamine. Some trade or other names: AMT.  (38) 5-methoxy-N,N-diisopropyltryptamine.  Some  trade or other names: 5-MeO-DIPT.  (e) Depressants. Unless specifically  excepted  or  unless  listed  in another  schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances  having  a  depressant effect  on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence  of  such  salts,  isomers,  and salts of isomers is possible within the specific chemical designation:  (1) Mecloqualone.  (2) Methaqualone.  (3) Phencyclidine.  (4)  Gamma  hydroxybutyric  acid,  and  salt, hydroxybutyric compound, derivative or preparation of gamma hydroxybutyric  acid,  including  any isomers,  esters  and  ethers and salts of isomers, esters and ethers of gamma hydroxybutyric  acid,  except  gamma-butyrolactone,  whenever  the existence  of  such  isomers,  esters  and  ethers and salts is possible within the specific chemical.  (5) Gamma-butyrolactone, including butyrolactone; butyrolactone gamma; 4-butyrolactone;   2(3H)-furanone    dihydro;    dihydro-2(3H)-furanone; tetrahydro-2-furanone;   1,2-butanolide;  1,4-butanolide;  4-butanolide; gamma-hydroxybutyric acid lactone;  3-hydroxybutyric  acid  lactone  and 4-hydroxybutanoic  acid  lactone  with  Chemical Abstract Service number (96-48-0) when any such substance is intended for human consumption.  (6) 1,4    butanediol,    including    butanediol;    butane-1,4-diol; 1,4-butylene     glyco;     butylene     glycol;    1,4-dihydroxybutane; 1,4-tetramethylene   glycol;   tetramethylene   glycol;   tetramethylene Abstract  Service  number (110-63-4) when any such substance is intended for human consumption.  (f) Stimulants. Unless  specifically  excepted  or  unless  listed  in another  schedule, any material, compound, mixture, or preparation which contains any quantity of the following  substances  having  a  stimulant effect  on the central nervous system, including its salts, isomers, and salts of isomers:  (1) Fenethylline.  (2) N-ethylamphetamine.  (3) (+ -)cis-4-methylaminorex ((+ -)cis-4,5-dihydro-4-methyl -5-phenyl -2-oxazolamine).  (4) N,N-dimethylamphetamine also     known     as      N,N-alpha- trimethyl-benzeneethanamine; N,N-alpha- trimethylphenethylamine).  (5) Methcathinone  (some other names: 2-(methylamino) - propiophenone; alpha-(methylamino)   propiophenone;    2-(methylamino) -1-phenylpropan- 1-one;  alpha-N- methylaminopropiophenone; monomethylpropion; ephedrone, N-methylcathinone, methylcathinone; AL-464; AL-422; AL-463 and  UR1432), its salts, optical isomers and salts of optical isomers.  (6)   Aminorex.   Some   other  names:  aminoxaphen;  2-amino-5-phenyl -2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine.  (7)     Cathinone.      Some      trade      or      other      names: 2-amino-1-phenyl-1-propanone,                  alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone.  (8) N-benzylpiperazine (some other  names:  BZP;  1-benzylpiperazine), its optical isomers, salts and salts of isomers.  (9) 4-methyl-N-methylcathinone or 4-Methylmethcathinone, also known as Mephedrone.  (10)   3,4-methylenedioxypyrovalerone  or  Methylenedioxypyrovalerone, also known as MDPV.  (11)   3,4-methylenedioxy-N-methylcathinone   (some    other    names: methylone).  (12) 4-Methoxymethcathinone.  (13) 3-Fluoromethcathinone.  (14) 4-Fluoromethcathinone.  (15) Ethylpropion (Ethcathinone).  (16) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).  (17) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).  (18) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).  (19) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).  (20) 2-{4-(Ethylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-2).  (21) 2-{4-(Isopropylthio)-2,5-dimethoxyphenyl}ethanamine (2C-T-4).  (22) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).  (23) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).  (24) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).  (g)  Synthetic  cannabinoids.  Unless  specifically excepted or unless listed  in  another  schedule,  any  material,  compound,  mixture,   or preparation,  which  contains  any  quantity  of the following synthetic cannabinoid substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence  of  such  salts,  isomers,  and salts  of  isomers  is possible within the specific chemical designation (for purposes of this paragraph only, the  term  "isomer"  includes  the optical, position and geometric isomers):  (1) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone.  Some trade or other names: UR-144.  (2) {1-(5-fluro-pentyl)-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl) methanone. Some trade names or other names: 5-fluoro-UR-144, XLR11.  (3) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide.  Some trade or other names: APINACA, AKB48.  (4) quinolin-8-yl  1-pentyl-1H-indole-3-carboxylate.  Some  trade   or other names: PB-22; QUPIC.  (5) quinolin-8-yl   1-(5-fluoropentyl)-1H-indole-3-carboxylate.   Some trade or other names: 5-fluoro-PB-22; 5F-PB-22.  (6) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazo- le-3-carboxamide. Some trade or other names: AB-FUBINACA.  (7) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide. Some trade or other names: ADB-PINACA.  (8) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H- indazole-3-carboxamide. Some trade or other names: AB-CHMINACA.  (9) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide. Some trade or other names: AB-PINACA.  (10) {1-(5-fluoropentyl)-1H-indazol-3-yl}(naphthalen-1-y1)methanone. Some trade or other names: THJ-2201.  (h) (1) Cannabimimetic agents. Unless specifically exempted or  unless listed   in  another  schedule,  any  material,  compound,  mixture,  or preparation  that  is  not  approved  by  the  federal  food  and   drug administration  (FDA)  which  contains  any  quantity  of cannabimimetic agents, or which contains their salts, isomers,  and  salts  of  isomers whenever  the  existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.  (2) As used in this  subdivision,  the  term  "cannabimimetic  agents" means any substance that is a cannabinoid receptor type 1 (CB1 receptor) agonist  as demonstrated by binding studies and functional assays within any of the following structural classes:  (i) 2-(3-hydroxycyclohexyl)phenol with substitution at the  5-position of  the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.  (ii)   3-(1-naphthoyl)indole   or    3-(1-naphthylmethane)indole    by substitution  at  the  nitrogen  atom of the indole ring, whether or not  further substituted on the indole ring to any  extent,  whether  or  not substituted on the naphthoyl or naphthyl ring to any extent.  (iii)  3-(1-naphthoyl)pyrrole  by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring  to  any extent.  (iv)  1-(1-naphthylmethylene)indene  by substitution of the 3-position of the indene ring, whether or not further  substituted  in  the  indene ring  to  any extent, whether or not substituted on the naphthyl ring to any extent.  (v) 3-phenylacetylindole or 3-benzoylindole  by  substitution  at  the nitrogen  atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the  phenyl ring to any extent.  (3) Such term includes:  (i)      5-(1,1-dimethylheptyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol (CP-47,497);  (ii)      5-(1,1-dimethyloctyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);  (iii) 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);  (iv) 1-butyl-3-(1-naphthoyl)indole (JWH-073);  (v) 1-hexyl-3-(1-naphthoyl)indole (JWH-019);  (vi) 1-{2-(4-morpholinyl)ethyl}-3-(1-naphthoyl)indole (JWH-200);  (vii) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);  (viii) 1-pentyl-3-{1-(4-methoxynaphthoyl)}indole (JWH-081);  (ix) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);  (x) 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);  (xi) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201);  (xii) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);  (xiii) 1-pentyl-3-{(4-methoxy)-benzoyl}indole (SR-19 and RCS-4);  (xiv)   1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole  (SR-18  and RCS-8); and  (xv) 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203).   Schedule II. (a) Schedule II shall consist  of  the  drugs  and  other substances,  by  whatever  official name, common or usual name, chemical name, or brand name designated, listed in this section.  (b)  Substances,  vegetable  origin  or  chemical  synthesis.   Unless specifically  excepted  or unless listed in another schedule, any of the following  substances  whether  produced  directly  or   indirectly   by extraction  from  substances  of  vegetable  origin, or independently by means of chemical synthesis, or  by  a  combination  of  extraction  and chemical synthesis:  (1)   Opium  and  opiate,  and  any  salt,  compound,  derivative,  or preparation of opium  or  opiate,  excluding  apomorphine,  dextrorphan, nalbuphine,  nalmefene,  naloxone,  and naltrexone, and their respective salts, but including the following:   1. Raw opium.   2. Opium extracts.   3. Opium fluid.   4. Powdered opium.   5. Granulated opium.   6. Tincture of opium.   7. Codeine.   8. Ethylmorphine.   9. Etorphine hydrochloride.   10. Hydrocodone (also known as dihydrocodeinone).   11. Hydromorphone.   12. Metopon.    13. Morphine.   14. Oxycodone.   15. Oxymorphone.   16. Thebaine.   17. Dihydroetorphine.   18. Oripavine.  (2)  Any  salt,  compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the  substances  referred to  in  this section, except that these substances shall not include the isoquinoline alkaloids of opium.  (3) Opium poppy and poppy straw.  (4) Coca leaves and any salt, compound, derivative, or preparation  of coca  leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances including cocaine and ecgonine,  their  salts,  isomers,  and  salts  of isomers,  except that the substances shall not include: (A) decocainized coca leaves or extraction of  coca  leaves,  which  extractions  do  not contain cocaine or ecgonine; or (B) {123I} ioflupane.  (5)  Concentrate  of  poppy straw (the crude extract of poppy straw in either liquid, solid or powder  form  which  contains  the  phenanthrene alkaloids of the opium poppy).  (b-1)  Unless  specifically  excepted  or  unless  listed  in  another schedule, any material, compound, mixture, or preparation containing any of the following, or their salts calculated as the free  anhydrous  base or alkaloid, in limited quantities as set forth below:  (1)  Not  more  than  three  hundred  milligrams  of  dihydrocodeinone (hydrocodone) per one hundred  milliliters  or  not  more  than  fifteen milligrams  per  dosage  unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.  (2)  Not  more  than  three  hundred  milligrams  of  dihydrocodeinone (hydrocodone)  per  one  hundred  milliliters  or  not more than fifteen milligrams  per  dosage  unit,  with  one  or  more  active  nonnarcotic ingredients in recognized therapeutic amounts.  (c)  Opiates.  Unless  specifically  excepted  or  unless  in  another schedule any of the following opiates, including  its  isomers,  esters, ethers,  salts  and  salts  of  isomers,  esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible  within the  specific  chemical  designation,  dextrorphan  and levopropoxyphene excepted:  (1) Alfentanil.  (2) Alphaprodine.  (3) Anileridine.  (4) Bezitramide.  (5) Bulk dextropropoxyphene (non-dosage forms).  (6) Carfentanil.  (7) Dihydrocodeine.  (8) Diphenoxylate.  (9) Fentanyl.  (10) Isomethadone.  (11) Levo-alphacetylmethadol (also known as levo-alpha-acetylmethadol, levomethadylacetate or LAAM).  (12) Levomethorphan.  (13) Levorphanol.  (14) Metazocine.  (15) Methadone.  (16) Methadone-intermediate,   4-cyano-2-dimethylamino-4,   4-diphenyl butane.  (17) Moramide-intermediate, 2-methyl-3-morpholino-1, 1--diphenylpropane--carboxylic acid.  (18) Pethidine (meperidine).  (19) Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine.  (20) Pethidine-intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate.  (21) Pethidine-intermediate-C,    1--methyl--4-- phenylpiperidine--4-- carboxylic acid.  (22) Phenazocine.  (23) Piminodine.  (24) Racemethorphan.  (25) Racemorphan.  (26) Sufentanil.  (27) Remifentanil.  (28) Tapentadol.  (29) Thiafentanil.  (d) Stimulants. Unless  specifically  excepted  or  unless  listed  in another  schedule, any material, compound, mixture, or preparation which contains any quantity of the following  substances  having  a  stimulant effect  on the central nervous system, including its salts, isomers, and salts of isomers:  (1) Amphetamine.  (2) Methamphetamine.  (3) Phenmetrazine.  (4) Methylphenidate.  (5) Lisdexamfetamine.  (e) Depressants. Unless specifically  excepted  or  unless  listed  in another  schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances  having  a  depressant effect  on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence  of  such  salts,  isomers,  and salts of isomers is possible within the specific chemical designation:  (1) Amobarbital.  (2) Glutethimide.  (3) Pentobarbital.  (4) Secobarbital.  (f) Hallucinogenic substances.   Nabilone:      Another      name     for     nabilone:   (+,-)-trans -3-(1,1-dimethylheptyl)-6,  6a,  7,  8,  10,  10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo{b,d}pyran-9-one.  (g)  Immediate  precursors.  Unless  specifically  excepted  or unless listed  in  another  schedule,  any  material,  compound,   mixture   or preparation which contains any quantity of the following substances:  (1) Immediate precursor to amphetamine and methamphetamine:  (i)  Phenylacetone Some trade or other names: pheny1-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;  (2) Immediate precursors to phencyclidine (PCP):  (i) 1-phenylcyclohexylamine;  (ii) 1-piperidinocyclohexanecarbonitrile (PCC).  (3) Immediate precursor to fentanyl:  (i) 4-anilino-N-phenethyl-4-piperidine (ANPP).  (h) Anabolic steroids. Unless specifically excepted or  unless  listed in  another schedule, "anabolic steroid" shall mean any drug or hormonal substance, chemically  and  pharmacologically  related  to  testosterone (other     than     estrogens,     progestins,    corticosteroids    and dehydroepiandrosterone) and includes:  (1) 3{beta}, 17-dihydroxy-5a-androstane.  (2) 3{alpha}, 17{beta}-dihydroxy-5a-androstane.  (3) 5{alpha}-androstan-3,17-dione.  (4) 1-androstenediol (3{beta},17{beta}-dihydroxy-5{alpha}-androst-1- ene).  (5) 1-androstenediol (3{alpha},17{beta}-dihydroxy-5{alpha}-androst-1- ene).  (6) 4-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-4-ene).  (7) 5-androstenediol (3{beta}, 17{beta}-dihydroxy-androst-5-ene).  (8) 1-androstenedione ({5{alpha}}-androst-1-en-3,17-dione).  (9) 4-androstenedione (androst-4-en-3,17-dione).  (10) 5-androstenedione (androst-5-en-3,17-dione).  (11) Bolasterone (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyandrost- 4-en-3-one).  (12) Boldenone (17{beta}-hydroxyandrost-1, 4,-diene-3-one).  (13) Boldione (androsta-1,4-diene-3,17-dione).  (14) Calusterone (7{beta}, 17{alpha}-dimethyl-17{beta}-hydroxyandrost- 4-en-3-one).  (15) Clostebol (4-chloro-17{beta}-hydroxyandrost-4-en-3-one).  (16) Dehydrochloromethyltestosterone 4-chloro-17{beta}-hydroxy-17 {alpha}-methyl-androst-1, 4-dien-3-one).  (17)  {Delta}  1-dihydrotestosterone  (a.k.a.  '1-testosterone')   (17 {beta}-hydroxy-5{alpha}-androst-1-en-3-one).  (18) 4-dihydrotestosterone (17{beta}-hydroxy-androstan-3-one).  (19)      Drostanolone  17{beta}-hydroxy-2{alpha}-methyl-5{alpha} -androstan-3-one).  (20) Ethylestrenol (17{alpha}-ethyl-17{beta}-hydroxyestr- 4-ene).  (21) Fluoxymesterone (9-fluoro-17{alpha}-methyl-11{beta},  17  {beta}- dihydroxyandrost-4-en-3-one).  (22)         Formebolone     2-formyl-17{alpha}-methyl-11{alpha}, 17{beta}-dihydroxyandrost-1, 4-dien-3-one).  (23) Furazabol (17{alpha}-methyl-17{beta}-hydroxyandrostano {2, 3-c}-furazan).  (24) 13{beta}-ethyl-17{beta}-hyroxygon-4-en-3-one.  (25) 4-hydroxytestosterone (4, 17{beta}-dihydroxy-androst-4-en-3-one).  (26)                                      4-hydroxy-19-nortestosterone (4,17{beta}-dihydroxy-estr-4-en-3-one).  (27)                                          desoxymethyltestosterone (17{alpha}-methyl-5{alpha}-androst-2-en-17{beta}-ol) (a.k.a., madol).  (28) Mestanolone               17{alpha}-methyl-17{beta}-hydroxy- 5-androstan-3-one).  (29) Mesterolone (1{alpha}                    methyl-17{beta}-hydroxy- {5{alpha}}-androstan-3-one).  (30)        Methandienone (17{alpha}-methyl-17{beta}-hydroxyandrost-1, 4-dien-3-one).  (31)               Methandriol          17{alpha}-methyl-3{beta}, 17{beta}-dihydroxyandrost-5-ene).  (32)     Methenolone  1-methyl-17{beta}-hydroxy-5{alpha}-androst- 1-en-3-one).  (33) 17{alpha}-methyl-3{beta},17{beta}-dihydroxy-5a-androstane.  (34) 17{alpha}-methyl-3{alpha}, 17{beta}-dihydroxy- 5a-androstane.  (35) 17{alpha}-methyl-3{beta}, 17{beta}-dihydroxyandrost-4-ene.  (36)     17{alpha}-methyl-4-hydroxynandrolone 17{alpha}-methyl-4- hydroxy-17{beta}-hydroxyestr-4-en-3-one).  (37)     Methyldienolone  17{alpha}-methyl-17{beta}-hydroxyestra- 4,9(10)-dien-3-one).  (38)    Methyltrienolone17{alpha}-methyl-17{beta}-hydroxyestra-4, 9-11-trien-3-one).  (39)   Methyltestosterone   (17{alpha}-methyl-17{beta}-hydroxyandrost- 4-en-3-one).  (40)   Mibolerone   (7{alpha},17{alpha}-dimethyl-17{beta}-hydroxyestr- 4-en-3-one).  (41) 17{alpha}-methyl-{Delta} 1-dihydrotestosterone (17b{beta}-hydroxy-17{alpha}-methyl-5{alpha}-androst-1-en-3-one) (a.k.a. '17-{alpha}-methyl-1-testosterone').  (42) Nandrolone(17{beta}-hydroxyestr-4-en-3-one).  (43) 19-nor-4-androstenediol (3{beta},17{beta}-dihydroxyestr -4-ene).  (44) 19-nor-4-androstenediol (3{alpha},17{beta}-dihydroxyestr-4-ene).  (45) 19-nor-5-androstenediol (3{beta},17{beta}-dihydroxyestr -5-ene).  (46) 19-nor-5-androstenediol (3{alpha},17{beta}-dihydroxyestr-5-ene).  (47)                                 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione).  (48) 19-nor-4-androstenedione (estr-4-en-3,17-dione).  (49) 19-nor-5-androstenedione (estr-5-en-3,17-dione).  (50)      Norbolethone  13{beta},      17{alpha}-diethyl-17{beta} -hydroxygon-4-en-3-one).  (51) Norclostebol (4-chloro-17{beta}-hydroxyestr-4-en-3-one).  (52)       Norethandrolone  17{alpha}-ethyl-17{beta}-hydroxyestr- 4-en-3-one).  (53)            Normethandrolone        17{alpha}-methyl-17{beta} -hydroxyestr-4-en-3-one).  (54)       Oxandrolone   17{alpha}-methyl-17{beta}-hydroxy-2-oxa- {5{alpha}}-androstan-3-one).  (55)     Oxymesterone 17{alpha}-methyl-4,      17{beta}-dihydroxy androst-4-en-3-one).  (56)     Oxymetholone 17     {alpha}-methyl-2-hydroxymethylene-17 {beta}-hydroxy-{5{alpha}}- androstan-3-one).  (57)     Stanozolol 17{alpha}-methyl-17{beta}-hydroxy-{5{alpha}}- androst-2-eno{3, 2-c}-pyrazole).  (58)     Stenbolone 17{beta}-hydroxy-2-methyl-{5{alpha}}-androst- 1-en-3-one).  (59)     Testolactone 13-hydroxy-3-oxo-13,     17-secoandrosta-1, 4-dien-17-oic acid lactone).  (60) Testosterone (17{beta}-hydroxyandrost-4-en-3-one).  (61)       Tetrahydrogestrinone  13{beta},      17{alpha}-diethyl -17{beta}-hydroxygon-4, 9, 11-trien-3-one).  (62) Trenbolone (17{beta}-hydroxyestr-4, 9, 11-trien-3-one).  (63) Any salt, ester or ether of a  drug  or  substance  described  or listed in this subdivision.  (i)  Subdivision  (h)  of this section shall not include any substance containing  anabolic  steroids  expressly  intended  for  administration through  implants  to  cattle  or  other  nonhuman  species and that are approved by the federal food and drug  administration  solely  for  such use.   Any individual who knowingly and willfully administers to himself or another person, prescribes, dispenses or distributes such  substances for  other  than  implantation  to  cattle  or nonhuman species shall be subject to the  same  penalties  as  a  practitioner  who  violates  the provisions of this section or any other penalties prescribed by law.   Schedule  III.  (a)  Schedule III shall consist of the drugs and other substances, by whatever official name, common or  usual  name,  chemical name, or brand name designated, listed in this section.  (b)  Stimulants.  Unless  specifically  excepted  or  unless listed in another schedule, any material, compound, mixture, or preparation  which contains  any  quantity  of  the following substances having a stimulant effect on the central  nervous  system,  including  its  salts,  isomers (whether  optical,  position,  or  geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of  isomers  is possible within the specific chemical designation:  (1)  Those  compounds,  mixtures,  or preparations in dosage unit form containing  any  stimulant  substances  listed  in  schedule  II   which compounds,  mixtures, or preparations were listed on August twenty-five, nineteen  hundred  seventy-one,  as  excepted  compounds   under   title twenty-one,  section  308.32  of the code of federal regulations and any other drug of the quantitive composition shown in that  list  for  those drugs  or which is the same except that it contains a lesser quantity of controlled substances.  (2) Benzphetamine.  (3) Chlorphentermine.  (4) Clortermine.  (6) Phendimetrazine.  (c) Depressants. Unless specifically  excepted  or  unless  listed  in another  schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances  having  a  depressant effect  on the central nervous system, including its salts, isomers, and salts of isomers:  (1) Any compound, mixture or preparation containing:  (i) Amobarbital;  (ii) Secobarbital;  (iii) Pentobarbital; or any salt thereof and one or more other active  medicinal  ingredients which are not listed in any schedule.  (2) Any suppository dosage form containing:  (i) Amobarbital;  (ii) Secobarbital;  (iii) Pentobarbital; or  any  salt of any of these drugs and approved by the federal food and drug administration for marketing only as a suppository.  (3) Any substance which contains  any  quantity  of  a  derivative  of barbituric acid or any salt thereof.  (4) Chlorhexadol.  (5) Lysergic acid.  (6) Lysergic acid amide.  (7) Methyprylon.  (8) Sulfondiethylmethane.  (9) Sulfonethylmethane.  (10) Sulfonmethane.  (11) Tiletamine and zolazepam or any salt thereof. Some trade or other names  for  a  tiletamine-zolazepam combination product: Telazol.   Some trade or  other  names  for  tiletamine:  2-(ethylamino)  -2-(2-thienyl) -cyclohexanone.    Some    trade   or   other   names   for   zolazepam: 4-(2-fluorophenyl) -6,8-dihydro -1,   3,    8i-trimethylpyrazolo-{3,4-e} {1,4} -diazepin-7(1H)-one, flupyrazapon.  (12)  Gamma  hydroxybutyric  acid,  and salt, hydroxybutyric compound, derivative or preparation of gamma hydroxybutyric  acid,  including  any isomers,  esters  and  ethers and salts of isomers, esters and ethers of gamma hydroxybutyric acid, contained in a  drug  product  for  which  an application  has  been  approved  under section 505 of the federal food, drug and cosmetic act.  (13) Ketamine,  its  salts,  isomers  and salts   of   isomers   (some other   names   for   ketamine:  (±)-2-(2-chlorophenyl)-2-(methylamino)- cyclohexanone).  (14) Embutramide.  (d) Nalorphine.  (e) Narcotic drugs. Unless specifically excepted or unless  listed  in another  schedule,  any  material,  compound,  mixture,  or  preparation containing  any  of  the  following  narcotic  drugs,  or  their   salts  calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:  (1)  Not more than 1.8 grams of codeine per one hundred milliliters or not more than ninety milligrams  per  dosage  unit,  with  an  equal  or greater quantity of an isoquinoline alkaloid of opium.  (2)  Not more than 1.8 grams of codeine per one hundred milliliters or not more than ninety milligrams  per  dosage  unit,  with  one  or  more active, nonnarcotic ingredients in recognized therapeutic amounts.  (3)  Not  more  than  1.8  grams  of  dihydrocodeine  per  one hundred milliliters or not more than ninety milligrams per dosage unit, with one or  more  active  nonnarcotic  ingredients  in  recognized   therapeutic amounts.  (4)  Not  more  than three hundred milligrams of ethylmorphine per one hundred milliliters or not more than fifteen milligrams per dosage unit, with  one  or  more  active,  nonnarcotic  ingredients   in   recognized therapeutic amounts.  (5)  Not  more  than  five hundred milligrams of opium per one hundred milliliters or per one  hundred  grams  or  not  more  than  twenty-five milligrams  per  dosage  unit,  with  one  or  more  active, nonnarcotic ingredients in recognized therapeutic amounts.  (6) Not more  than  fifty  milligrams  of  morphine  per  one  hundred milliliters  or  per  one  hundred  grams,  with  one  or  more  active, nonnarcotic ingredients in recognized therapeutic amounts.  (7) Buprenorphine in any quantities.  (f) Dronabinol (synthetic) in sesame oil and encapsulated  in  a  soft gelatin capsule in a U.S. Food and Drug Administration approved product.   Some  other  names  for  dronabinol  include:  (6aR-trans)-6a,  7,  8, 10a-tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo{b,d} pyran-1-o1, or (-)-delta-9-(trans) - tetrahydrocannabinol.  (g) Chorionic gonadotropin. (1) Unless specifically excepted or unless listed  in  another  schedule  any  material,  compound,   mixture,   or preparation which contains any amount of chorionic gonadotropin.  (2)  Paragraph one of this subdivision shall not include any substance containing chorionic gonadotropin expressly intended for  administration through  implants  or  injection to cattle or other nonhuman species and that are approved by the federal food and drug administration solely for such use. Any individual who  knowingly  and  willfully  administers  to himself  or  another  person,  prescribes, dispenses or distributes such substances for  other  than  implantation  or  injection  to  cattle  or nonhuman   species   shall  be  subject  to  the  same  penalties  as  a practitioner who violates the provisions of this section  or  any  other penalties prescribed by law.   Schedule  IV.  (a)  Schedule  IV  shall consist of the drugs and other substances, by whatever official name, common or  usual  name,  chemical name, or brand name designated, listed in this section.  (b)  Narcotic  drugs. Unless specifically excepted or unless listed in another  schedule,  any  material,  compound,  mixture,  or  preparation containing   any  of  the  following  narcotic  drugs,  or  their  salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:  (1) Not more than  one  milligram  of  difenoxin  and  not  less  than twenty-five micrograms of atropine sulfate per dosage unit.  (2) Dextropropoxyphene   (alpha-(+)-4-dimethylamino-1,   2-diphenyl-3- methyl-2-propionoxybutane).  (c) Depressants. Unless specifically  excepted  or  unless  listed  in another  schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its  salts, isomers,  and  salts  of  isomers  whenever the existence of such salts,  isomers, and salts of isomers is possible within the  specific  chemical designation:  (1) Alprazolam.  (2) Barbital.  (3) Bromazepam.  (4) Camazepam.  (5) Chloral betaine.  (6) Chloral hydrate.  (7) Chlordiazepoxide.  (8) Clobazam.  (9) Clonazepam.  (10) Clorazepate.  (11) Clotiazepam.  (12) Cloxazolam.  (13) Delorazepam.  (14) Diazepam.  (15) Estazolam.  (16) Ethchlorvynol.  (17) Ethinamate.  (18) Ethyl Loflazepate.  (19) Fludiazepam.  (20) Flunitrazepam.  (21) Flurazepam.  (22) Halazepam.  (23) Haloxazolam.  (24) Ketazolam.  (25) Loprazolam.  (26) Lorazepam.  (27) Lormetazepam.  (28) Mebutamate.  (29) Medazepam.  (30) Meprobamate.  (31) Methohexital.  (32) Methylphenobarbital (mephobarbital).  (33) Nimetazepam.  (34) Nitrazepam.  (35) Nordiazepam.  (36) Oxazepam.  (37) Oxazolam.  (38) Paraldehyde.  (39) Petrichoral.  (40) Phenobarbital.  (41) Pinazepam.  (42) Prazepam.  (43) Temazepam.  (44) Tetrazepam.  (45) Triazolam.  (46) Midazolam.  (47) Quazepam.  (48) Zolpidem.  (49) Dichloralphenazone.  (50) Zaleplon.  (51) Zopiclone (eszopiclone).  (52) Fospropofol.  (53) Carisoprodol.   * (d)  Fenfluramine.  Any  material, compound, mixture, or preparation which contains any quantity of the following substances,  including  its salts,  isomers  (whether optical, position, or geometric), and salts of  such isomers, whenever the existence of such salts, isomers and salts of isomers is possible:  (1) Fenfluramine.   * NB  Repealed  upon  the  removal  of  fenfluramine and its salts and isomers from Schedule IV of the federal Controlled Substances Act  (e) Stimulants. Unless  specifically  excepted  or  unless  listed  in another  schedule, any material, compound, mixture, or preparation which contains any quantity of the following  substances  having  a  stimulant effect  on the central nervous system, including its salts, isomers, and salts of such isomers:  (1) Cathine ((+) - norpseudoephedrine).  (2) Diethylpropion.  (3) Fencamfamin.  (4) Fenproporex.  (5) Mazindol.  (6) Mefenorex.  (7)  Pemoline  (including  organometallic   complexes   and   chelates thereof).  (8) Phentermine.  (9) Pipradrol.  (10) SPA((-))-1-dimethylamino-1, 2-diphenylethane).  (11) Modafinil.  (12) Sibutramine.  (f) Other substances. Unless specifically excepted or unless listed in another  schedule,  any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:  (1) Pentazocine.  (2) Butorphanol (including its optical isomers).  (3) Tramadol in any quantities.   Schedule V. (a) Schedule V  shall  consist  of  the  drugs  and  other substances,  by  whatever  official name, common or usual name, chemical name, or brand name designated, listed in this section.  (b)   Narcotic   drugs   containing   nonnarcotic   active   medicinal ingredients.    Any  compound, mixture, or preparation containing any of the following narcotic drugs, or their  salts  calculated  as  the  free anhydrous  base  or  alkaloid, in limited quantities as set forth below, which shall include one or more nonnarcotic active medicinal ingredients in sufficient proportion  to  confer  upon  the  compound,  mixture,  or preparation  valuable  medicinal qualities other than those possessed by narcotic drugs alone:  (1) Not more than two hundred milligrams of codeine  per  one  hundred milliliters or per one hundred grams.  (2)  Not  more  than  one hundred milligrams of dihydrocodeine per one hundred milliliters or per one hundred grams.  (3) Not more than one hundred  milligrams  of  ethylmorphine  per  one hundred milliliters or per one hundred grams.  (4)  Not  more  than 2.5 milligrams of diphenoxylate and not less than twenty-five micrograms of atropine sulfate per dosage unit.  (5) Not more than one hundred milligrams  of  opium  per  one  hundred milliliters or per one hundred grams.  (6)  Not  more  than  0.5  milligram  of  difenoxin  and not less than twenty-five micrograms of atropine sulfate per dosage unit.  (c) Stimulants. Unless specifically exempted  or  excluded  or  unless listed   in  another  schedule,  any  material,  compound,  mixture,  or preparation which contains any  quantity  of  the  following  substances having  a  stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:  (1) Pyrovalerone.  (d) Depressants. Unless specifically exempted or  excluded  or  unless listed   in  another  schedule,  any  material,  compound,  mixture,  or preparation which contains any  quantity  of  the  following  substances having  a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers:  (1)   Ezogabine   {N-{2-amino-4-(4-fluorobenzylamino)-phenyl}-carbamic acid ethyl ester}.  (2) Lacosamide {(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide}.  (3) Pregabalin {(S)-3-(aminomethyl)-5-methylhexanoic acid }.